The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Xp11.2 translocation renal cell carcinoma in the autosomal dominant polycystic kidney disease patient with preserved renal function

  • Huh, Hyuk (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital) ;
  • Jo, Hyung Ah (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital) ;
  • Yi, YongJin (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital) ;
  • Kim, Seung Hyup (Department of Radiology, Seoul National University Hospital) ;
  • Moon, Kyung Chul (Department of Pathology, Seoul National University Hospital) ;
  • Ahn, Curie (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital) ;
  • Park, Hayne Cho (Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital)
  • Received : 2014.05.14
  • Accepted : 2014.07.08
  • Published : 2017.11.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Hajj P, Ferlicot S, Massoud W, et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 2009;74:631-634. https://doi.org/10.1016/j.urology.2009.02.078
  2. Keith DS, Torres VE, King BF, Zincki H, Farrow GM. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994;4:1661-1669.
  3. Na KY, Kim HS, Park YK, Chang SG, Kim YW. Multifocal renal cell carcinoma of different histological subtypes in autosomal dominant polycystic kidney disease. Korean J Pathol 2012;46:382-386. https://doi.org/10.4132/KoreanJPathol.2012.46.4.382
  4. Klaassen Z, Tatem A, Burnette JO, Donohoe JM, Terris MK. Adult Xp11 translocation associated renal cell carcinoma: time to recognize. Urology 2012;80:965-968. https://doi.org/10.1016/j.urology.2012.07.051
  5. Tsuda M, Davis IJ, Argani P, et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res 2007;67:919-929. https://doi.org/10.1158/0008-5472.CAN-06-2855

Cited by

  1. Bilateral Laparoscopic Nephrectomy in Autosomal Dominant Polycystic Kidney Disease with Bilateral Renal Masses: A Feasible Option vol.6, pp.4, 2020, https://doi.org/10.1089/cren.2020.0104